• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Raymond T. Chung, MD


  • Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TR.Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis.Gastroenterology. 2013 May;144(5):1024-30.
  • Fusco DN, Brisac C, John SP, Huang YW, Chin CR, Xie T, Zhao H, Zhang L, Chevalier S, Wambua D, Lin W, Peng L, Chung RT, Brass AL.A Genetic Screen Identifies Interferon Alfa Effector Genes Required to Suppress Hepatitis C Virus Replication.Gastroenterology. 2013 Feb 24.
  • Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL.Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Ann Intern Med. 2013 Feb 19;158(4):235-45.
  • Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, Trevisan M, Gupta RM, Moisan A, Banks E, Friesen M, Schinzel RT, Xia F, Tang A, Xia Y, Figueroa E, Wann A, Ahfeldt T, Daheron L, Zhang F, Rubin LL, Peng LF, Chung RT, Musunuru K, Cowan CA.A TALEN genome-editing system for generating human stem cell-based disease models.Cell Stem Cell. 2013 Feb 7;12(2):238-51.
  • Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC, Jilg N, Kumthip K, Fusco DN, Peng LF, Chung RT.SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.Antiviral Res. 2013 Feb;97(2):101-7.
  • Jeong SW, Jang JY, Chung RT.Hepatitis C virus and hepatocarcinogenesis.Clin Mol Hepatol. 2012 Dec;18(4):347-56.
  • Rutherford A, King LY, Lee WM, Chung RT.Reply.Gastroenterology. 2013 Jan;144(1):e26.
  • Delgado-Borrego A, Smith L, Jonas MM, Hall CA, Negre B, Jordan SH, Ogrodowicz M, Raza R, Ludwig DA, Miller T, Lipshultz SE, Gonzalez-Peralta R, Chung RT.Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys.J Pediatr. 2012 Nov;161(5):915-21.
  • Huang YW, Chung RT.Management of hepatitis B reactivation in patients receiving cancer chemotherapy.Therap Adv Gastroenterol. 2012 Sep;5(5):359-70.
  • Sahani DV, Agarwal S, Chung RT.The double-edged sword of functional liver imaging.Radiology. 2012 Sep;264(3):621-3.
  • Kumthip K, Chusri P, Jilg N, Zhao L, Fusco DN, Zhao H, Goto K, Cheng D, Schaefer EA, Zhang L, Pantip C, Thongsawat S, O'Brien A, Peng LF, Maneekarn N, Chung RT, Lin W.Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.J Virol. 2012 Aug;86(16):8581-91.
  • Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PL.Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.J Am Chem Soc. 2012 Apr 25;134(16):6896-9.
  • Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, Chung RT, Degertekin B, Lok A, .Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.Clin Transplant. 2011 Mar;25(2):E152-E162.
  • Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RT, .A Functional Polymorphism in the Epidermal Growth Factor Gene is Associated with Risk for Hepatocellular Carcinoma.Gastroenterology. 2011 Mar 24.
  • Fusco DN, Chung RT.New protease inhibitors for HCV - Help is on the way.J Hepatol. 2011 Jan 11.
  • Chen JY, Chung RT.Can we use the "c" word with confidence? Cure for chronic hepatitis C.Gastroenterology. 2011 Mar;140(3):766-8.
  • Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, Polyak SJ, Chung RT, Yarmush ML, Nahmias Y.Naringenin Inhibits the Assembly and Long-Term Production of Infectious Hepatitis C Virus Particles Through a PPAR-Mediated Mechanism.J Hepatol. 2011 Feb 24.
  • Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT.The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.Dig Dis Sci. 2011 Feb;56(2):564-8.
  • Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, Berical AC, Feller AJ, Johnson KL, Schulze Zur Wiesch J, Robbins GK, Chung RT, Walker BD, Carrington M, Allen TM, Lauer GM.Spontaneous control of HCV is associated with the expression of HLA-B*57 and preservation of targeted epitopes.Gastroenterology. 2010 Sep 24.
  • Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT.IL28B inhibits Hepatitis C virus replication through the JAK-STAT pathway.J Hepatol. 2010 Dec 10.
  • Chung RT, Poordad FF, Hassanein T, Zhou X, Lentz E, Prabhakar A, Di Bisceglie AM.Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C.Hepatology. 2010 Dec;52(6):1906-14.
  • Jang JY, Chung RT.New treatments for chronic hepatitis C.Korean J Hepatol. 2010 Sep;16(3):263-77.
  • Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT, .Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C).J Acquir Immune Defic Syndr. 2010 Oct 1.
  • King LY, Chung RT.When treating cancer, please don't forget hepatitis B.Oncologist. 2010;15(8):826-9.
  • Moriguchi H, Chung RT, Mihara M, Sato C.Generation of human induced pluripotent stem cells from liver progenitor cells by only small molecules.Hepatology. 2010 Sep;52(3):1169; author reply 1169-70.
  • Méndez-Navarro J, Corey KE, Zheng H, Barlow LL, Jang JY, Lin W, Zhao H, Shao RX, McAfee SL, Chung RT.Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.Liver Int. 2010 Aug 25.
  • Méndez-Navarro J, Chirino RA, Corey KE, Gorospe EC, Zheng H, Morán S, Chung RT, Dehesa-Violante M.A Randomized Controlled Trial of Double Versus Triple Therapy with Amantadine for Genotype 1 Chronic Hepatitis C in Latino Patients.Dig Dis Sci. 2010 Sep;55(9):2629-35.
  • Delgado-Borrego A, Healey D, Negre B, Christofi M, Sabharwal S, Ludwig DA, Chung RT, Jonas MM.Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection.J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):191-7.
  • Contreras AM, Ochoa-Jiménez RJ, Celis A, Méndez C, Olivares L, Rebolledo CE, Hernandez-Lugo I, Aguirre-Zavala AI, Jiménez-Méndez R, Chung RT.High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection.Transfusion. 2010 Jun;50(6):1335-43.
  • Lin W, Tsai WL, Shao RX, Wu G, Peng LF, Barlow LL, Chung WJ, Zhang L, Zhao H, Jang JY, Chung RT.HCV regulates TGF-beta1 production through the generation of reactive oxygen species in an NFkappaB-dependent manner.Gastroenterology. 2010 Jun;138(7):2509-18, 2518.e1.
  • Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY, Tsai WL, Hyppolite G, Chung RT.Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.J Virol. 2010 Jun;84(12):6060-9.
  • Monto A, Schooley RT, Lai JC, Sulkowski MS, Chung RT, Pawlotsky JM, McHutchison JG, Jacobson IM.Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop.Am J Gastroenterol. 2010 May;105(5):989-1004; quiz 988, 1005. Review.
  • Chung RT.Reaping the early harvest of the genomics revolution.Gastroenterology. 2010 May;138(5):1653-4.
  • Delgado-Borrego A, Jordan SH, Negre B, Healey D, Lin W, Kamegaya Y, Christofi M, Ludwig DA, Lok AS, Chung RT, .Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C Trial.Clin Gastroenterol Hepatol. 2010 May;8(5):458-62.
  • Moriguchi H, Chung RT, Sato C.Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53.Hepatology. 2010 Mar;51(3):1088-9.
  • Moriguchi H, Chung RT, Sato C.An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells.Hepatology. 2010 Mar;51(3):1090-1.
  • Sherman KE, Soriano V, Chung RT.Human immunodeficiency virus and liver disease: Conference proceedings.Hepatology. 2010 Mar;51(3):1046-54.
  • Moriguchi H, Chung RT, Sato C.An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells.Hepatology. 2010 Mar;51(3):1085-6.
  • Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT, .Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.J Infect Dis. 2010 Mar;201(5):712-9.
  • Méndez-Navarro J, Chirino RA, Corey KE, Gorospe EC, Zheng H, Morán S, Juarez JA, Chung RT, Dehesa-Violante M.Erratum to: A Randomized Controlled Trial of Double Versus Triple Therapy with Amantadine for Genotype 1 Chronic Hepatitis C in Latino Patients.Dig Dis Sci. 2010 Jan 16.
  • Moriguchi H, Chung RT, Sato C.New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.Hepatology. 2010 Jan;51(1):344-5; author reply 345.
  • Moriguchi H, Chung RT, Sato C.An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.Hepatology. 2010 Jan;51(1):351-2.
  • Schiødt FV, Chung RT, Schilsky ML, Hay JE, Christensen E, Lee WM, .Outcome of acute liver failure in the elderly.Liver Transpl. 2009 Nov;15(11):1481-7.
  • Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RT.Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.Hepatology. 2009 Oct;50(4):1030-7.
  • Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, Lauwers GY.IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material.Mod Pathol. 2009 Oct;22(10):1287-95.
  • Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RT.Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.Infect Control Hosp Epidemiol. 2009 Oct;30(10):1000-5.
  • McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AY.Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.Clin Infect Dis. 2009 Oct 1;49(7):1051-60.
  • Kim AY, Chung RT.Coinfection with HIV-1 and HCV--a one-two punch.Gastroenterology. 2009 Sep;137(3):795-814. Review.
  • McGovern BH, Nagami EH, Birch CE, Bowen MJ, Reyor LL, Chung RT, Kim AY.Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection.J Infect Dis. 2009 Sep 15;200(6):877-81.
  • Everhart JE,Lok AS,Kim HY,Morgan TR,Lindsay KL,Chung RT,Bonkovsky HL,Ghany MG.Weight Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial.Gastroenterology. 2009 Aug;137(2):549-57.
  • Zúñiga J, Romero V, Azocar J, Terreros D, Vargas-Rojas MI, Torres-García D, Jiménez-Alvarez L, Vargas-Alarcón G, Granados-Montiel J, Husain Z, Chung RT, Alper CA, Yunis EJ.Protective KIR-HLA interactions for HCV infection in intravenous drug users.Mol Immunol. 2009 Aug;46(13):2723-7.
  • Nelson AL, Millington TM, Sahani D, Chung RT, Bauer C, Hertl M, Warshaw AL, Conrad C.Hepatic portal venous gas: the ABCs of management.Arch Surg. 2009 Jun;144(6):575-81; discussion 581. Review.
  • Welzel TM,Morgan TR,Bonkovsky HL,Naishadham D,Pfeiffer RM,Wright EC,Hutchinson AA,Crenshaw AT,Bashirova A,Carrington M,Dotrang M,Sterling RK,Lindsay KL,Fontana RJ,Lee WM,Di Bisceglie AM,Ghany MG,Gretch DR,Chanock SJ,Chung RT,O'Brien TR.Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.Hepatology. 2009 Jun;49(6):1847-58.
  • Corey KE,Shah N,Misdraji J,Abu Dayyeh BK,Zheng H,Bhan AK,Chung RT.The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.Liver Int. 2009 May;29(5):748-53.
  • Andersson KL,Chung RT.Monitoring during and after antiviral therapy for hepatitis B.Hepatology. 2009 May;49(5 Suppl):S166-73.
  • Lok AS,Everhart JE,Chung RT,Kim HY,Everson GT,Hoefs JC,Greenson JK,Sterling RK,Lindsay KL,Lee WM,Di Bisceglie AM,Bonkovsky HL,Ghany MG,Morishima C.Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.Hepatology. 2009 Jun;49(6):1828-37.
  • Tai AW,Benita Y,Peng LF,Kim SS,Sakamoto N,Xavier RJ,Chung RT.A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.Cell Host Microbe. 2009 Mar 19;5(3):298-307.
  • Tai AW,Chung RT.Racial differences in response to interferon-based antiviral therapy for hepatitis C virus infection: a hardwiring issue?.J Infect Dis. 2009 Apr 15;199(8):1101-3.
  • Shire NJ,Rao MB,Succop P,Buncher CR,Andersen JA,Butt AA,Chung RT,Sherman KE.Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.Clin Gastroenterol Hepatol. 2009 Apr;7(4):471-80, 480.e1-2.
  • Kim KA,Lin W,Tai AW,Shao RX,Weinberg E,De Sa Borges CB,Bhan AK,Zheng H,Kamegaya Y,Chung RT.Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.J Hepatol. 2009 Apr;50(4):705-11.
  • Tai AW,Chung RT.Treatment failure in hepatitis C: mechanisms of non-response.J Hepatol. 2009 Feb;50(2):412-20. Review.
  • Kuntzen T,Timm J,Berical A,Lennon N,Berlin AM,Young SK,Lee B,Heckerman D,Carlson J,Reyor LL,Kleyman M,McMahon CM,Birch C,Schulze Zur Wiesch J,Ledlie T,Koehrsen M,Kodira C,Roberts AD,Lauer GM,Rosen HR,Bihl F,Cerny A,Spengler U,Liu Z,Kim AY,Xing Y,Schneidewind A,Madey MA,Fleckenstein JF,Park VM,Galagan JE,Nusbaum C,Walker BD,Lake-Bakaar GV,Daar ES,Jacobson IM,Gomperts ED,Edlin BR,Donfield SM,Chung RT,Talal AH,Marion T,Birren BW,Henn MR,Allen TM.Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients.Hepatology. 2008 Dec;48(6):1769-78.
  • McGovern BH,Abu Dayyeh BK,Chung RT.Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection.Hepatology. 2008 Nov;48(5):1700-12.
  • Andersson KL,Salomon JA,Goldie SJ,Chung RT.Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.Clin Gastroenterol Hepatol. 2008 Dec;6(12):1418-24.
  • Sabharwal S,Delgado-Borrego A,Chung RT.Extrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction.Liver Transpl. 2008 Oct;14 Suppl 2:S51-7. Review.
  • Miller JC,Hahn PF,Chung RT,Thrall JH,Lee SI.Screening for hepatocellular carcinoma in cirrhotic patients.J Am Coll Radiol. 2008 Sep;5(9):1012-4.
  • Martin NM,Abu Dayyeh BK,Chung RT.Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.World J Gastroenterol. 2008 Jul 28;14(28):4573-5.
  • Morgan TR,Lambrecht RW,Bonkovsky HL,Chung RT,Naishadham D,Sterling RK,Fontana RJ,Lee WM,Ghany MG,Wright EC,O'Brien TR.DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.J Hepatol. 2008 Oct;49(4):548-56.
  • Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.Hepatology. 2008 Jul;48(1):59-69.
  • Abu Dayyeh BK,Chung RT.Broadly neutralizing antibodies against hepatitis C virus: new hope for immunization?.Gastroenterology. 2008 Jun;134(7):2184-6.
  • Nahmias Y, Goldwasser J, Casali M, van Poll D, Wakita T, Chung RT, Yarmush ML.Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.Hepatology. 2008 May;47(5):1437-45.
  • Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY.Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.Blood. 2008 May 15;111(10):5195-204.
  • Swan T, Chung RT.Development of novel agents for the treatment of hepatitis C virus.Hepatology. 2008 Apr;47(4):1426.
  • Romero V, Azocar J, Zuniga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C, Yunis EJ.Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.Mol Immunol. 2008 May;45(9):2429-36. Review.
  • O'Leary JG, Zachary K, Misdraji J, Chung RT.De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy.Clin Infect Dis. 2008 Jan 1;46(1):e12-4.
  • Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.JAMA. 2008 Jan 2;299(1):53-60.
  • Chung RT, Gale M Jr, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH.Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.Hepatology. 2008 Jan;47(1):306-20.
  • Kang M, Chung RT.The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons.J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):371-3.
  • Corey KE, Chung RT.Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope.Gastroenterology. 2007 Dec;133(6):2062-3.
  • Kim AY, Chung RT.Sex, drugs, and hepatitis C virus in men who have sex with men: evidence for permucosal transmission.Gastroenterology. 2007 Nov;133(5):1734-6; discussion 1736-7.
  • Tai AW, Chung RT.The hepatitis C virus plot thickens: enter claudin-1.Gastroenterology. 2007 Sep;133(3):1041-2.
  • Kuntzen T, Timm J, Berical A, Lewis-Ximenez LL, Jones A, Nolan B, Schulze zur Wiesch J, Li B, Schneidewind A, Kim AY, Chung RT, Lauer GM, Allen TM.Viral sequence evolution in acute hepatitis C virus infection.J Virol. 2007 Nov;81(21):11658-68.
  • Peng LF, Kim SS, Matchacheep S, Lei X, Su S, Lin W, Runguphan W, Choe WH, Sakamoto N, Ikeda M, Kato N, Beeler AB, Porco JA Jr, Schreiber SL, Chung RT.Identification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screen.Antimicrob Agents Chemother. 2007 Oct;51(10):3756-9.
  • Pekow JR, Bhan AK, Zheng H, Chung RT.Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.Cancer. 2007 Jun 15;109(12):2490-6.
  • Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, Kahn JA, Malet PF, Sheikh MY, Chung RT, Ghany MG, Gretch DR,.Portal Hypertensive Gastropathy in Chronic Hepatitis C Patients with Bridging Fibrosis and Compensated Cirrhosis: Results from the HALT-C Trial.Am J Gastroenterol. 2006 May 11;101(5):983-92.
  • Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD.Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors.Hepatology. 2005 Dec;42(6):1420-8.
  • McGuire BM, Bonkovsky HL, Carithers RL, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JR.Liver transplantation for erythropoietic protoporphyria liver disease.Liver Transpl. 2005 Dec;11(12):1590-6.
  • Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ,.Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.AIDS. 2005 May 20;19(8):767-73.
  • Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT.Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.Hepatology. 2005 Mar;41(3):660-7.
  • Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS.Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.Gastroenterology. 2005 Feb;128(2):313-27.
  • Chung RT.Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.Cancer. 2005 Feb 15;103(4):654-6.
  • Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Zur Wiesch JS, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, Allen TM.CD8 epitope escape and reversion in acute HCV infection.J Exp Med. 2004 Dec 20;200(12):1593-604.
  • Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.Liver Transpl. 2004 Nov;10(11):1343-54.
  • Hiasa Y, Kamegaya Y, Nuriya H, Onji M, Kohara M, Schmidt EV, Chung RT.Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.Am J Gastroenterol. 2003 Nov;98(11):2528-34.
  • Zhu AX, Chung RT.Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma?.Cancer. 2003 Jun 15;97(12):2948-50.
  • Leung JY, Abraczinskas DR, Bhan AK, Terella AM, Pascual M, Cosimi AB, Chung RT.Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone.Clin Transplant. 2003 Jun;17(3):275-83.
  • Chung RT, Feng S, Delmonico FL.Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor.Am J Transplant. 2001 Jul;1(2):185-91.
  • Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, Cosimi AB, Chung RT.Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria.Transplantation. 2002 Mar 27;73(6):911-5.
  • Ross AS, Graeme-Cook F, Cosimi AB, Chung RT.Combined liver and kidney transplantation in a patient with sickle cell disease.Transplantation. 2002 Feb 27;73(4):605-8.
  • Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT.Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.Am J Gastroenterol. 2002 Feb;97(2):478-83.
  • Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, Walker BD.Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.J Virol. 2002 Mar;76(6):2817-26.
  • Sherman KE, Rouster SD, Chung RT, Rajicic N.Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.Clin Infect Dis. 2002 Mar 15;34(6):831-7.
  • Chung RT, He W, Saquib A, Contreras AM, Xavier RJ, Chawla A, Wang TC, Schmidt EV.Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9847-52.
  • Abraczinskas DR, Chung RT.Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient.Transpl Infect Dis. 2000 Dec;2(4):186-93.
  • Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, Walker BD.Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.J Virol. 2001 Feb;75(3):1229-35.
  • Farrell JJ, Cosimi AB, Chung RT.Idiopathic giant esophageal ulcers in a renal transplant patient responsive to steroid therapy.Transplantation. 2000 Jul 15;70(1):230-2.
  • Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD.Analysis of successful immune responses in persons infected with hepatitis C virus.J Exp Med. 2000 May 1;191(9):1499-512.
  • Abrahamian GA, Cosimi AB, Farrell ML, Schoenfeld DA, Chung RT, Pascual M.Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation.Liver Transpl. 2000 Mar;6(2):185-90.
  • Baid S, Pascual M, Cosimi AB, Chung RT, Colvin RB, Tolkoff-Rubin N.Viruses and thrombotic microangiopathy.Transplantation. 1999 Sep 15;68(5):710-1.
  • Chung RT, Monto A, Dienstag JL, Kaplan LM.Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.J Med Virol. 1999 Aug;58(4):353-8.
  • Chung RT, Kaplan LM.Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.Biochem Biophys Res Commun. 1999 Jan 19;254(2):351-62.
  • Baid S, Pascual M, Williams WW, Tolkoff-Rubin N, Johnson SM, Collins B, Chung RT, Delmonico FL, Cosimi AB, Colvin RB.Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients.J Am Soc Nephrol. 1999 Jan;10(1):146-53.
  • Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi AB.Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.Transplantation. 1998 Nov 15;66(9):1254-8.
  • Pascual M, Thadhani R, Chung RT, Williams WW, Meehan S, Tolkoff-Rubin N, Colvin R, Cosimi AB.Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis.Transplantation. 1997 Oct 15;64(7):1073-6.
  • Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, Liang TJ.Transgenic expression of hepatitis C virus structural proteins in the mouse.Hepatology. 1997 Apr;25(4):1014-21.
  • Jaffe DL, Chung RT, Friedman LS.Management of portal hypertension and its complications.Med Clin North Am. 1996 Sep;80(5):1021-34.
  • Chung RT, Jaffe DL, Friedman LS.Complications of chronic liver disease.Crit Care Clin. 1995 Apr;11(2):431-63.
  • Chung RT, Kaplan LM.Parenterally transmitted hepatitis: viruses, vaccines, and antiviral therapy.Compr Ther. 1993;19(4):163-73.
  • Agnello V, Chung RT, Kaplan LM.A role for hepatitis C virus infection in type II cryoglobulinemia.N Engl J Med. 1992 Nov 19;327(21):1490-5.